These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24825127)

  • 1. Direct induction of ramified microglia-like cells from human monocytes: dynamic microglial dysfunction in Nasu-Hakola disease.
    Ohgidani M; Kato TA; Setoyama D; Sagata N; Hashimoto R; Shigenobu K; Yoshida T; Hayakawa K; Shimokawa N; Miura D; Utsumi H; Kanba S
    Sci Rep; 2014 May; 4():4957. PubMed ID: 24825127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
    Satoh J
    Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders.
    Ohgidani M; Kato TA; Kanba S
    Front Cell Neurosci; 2015; 9():184. PubMed ID: 26074765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.
    Satoh J; Kino Y; Motohashi N; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
    Neuropathology; 2015 Dec; 35(6):529-37. PubMed ID: 26087043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.
    Satoh J; Shimamura Y; Tabunoki H
    Cell Mol Neurobiol; 2012 Apr; 32(3):337-43. PubMed ID: 22080356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
    Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
    Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis.
    Errichiello E; Dardiotis E; Mannino F; Paloneva J; Mattina T; Zuffardi O
    Front Immunol; 2019; 10():1685. PubMed ID: 31396216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.
    Walter J
    J Biol Chem; 2016 Feb; 291(9):4334-41. PubMed ID: 26694609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
    Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
    Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasu-Hakola disease and primary microglial dysfunction.
    Bianchin MM; Martin KC; de Souza AC; de Oliveira MA; Rieder CR
    Nat Rev Neurol; 2010 Sep; 6(9):2 p following 523. PubMed ID: 20836191
    [No Abstract]   [Full Text] [Related]  

  • 11. Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology.
    Kaneko M; Sano K; Nakayama J; Amano N
    Neuropathology; 2010 Oct; 30(5):463-70. PubMed ID: 20500450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
    Varnum MM; Clayton KA; Yoshii-Kitahara A; Yonemoto G; Koro L; Ikezu S; Ikezu T
    J Biol Chem; 2017 Jun; 292(25):10651-10663. PubMed ID: 28490631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Shotgun Proteomic Platform for a Global Mapping of Lymphoblastoid Cells to Gain Insight into Nasu-Hakola Disease.
    De Palma A; Agresta AM; Viglio S; Rossi R; D'Amato M; Di Silvestre D; Mauri P; Iadarola P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.
    Giuliano S; Agresta AM; De Palma A; Viglio S; Mauri P; Fumagalli M; Iadarola P; Montalbetti L; Salvini R; Bardoni A
    PLoS One; 2014; 9(12):e110073. PubMed ID: 25470616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease.
    Galimberti D; Fenoglio C; Ghezzi L; Serpente M; Arcaro M; D'Anca M; De Riz M; Arighi A; Fumagalli GG; Pietroboni AM; Piccio L; Scarpini E
    Cytokine; 2019 Apr; 116():115-119. PubMed ID: 30690291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone matrix hypermineralization associated with low bone turnover in a case of Nasu-Hakola disease.
    Shboul M; Roschger P; Ganger R; Paschalis L; Rokidi S; Zandieh S; Behunova J; Muschitz C; Fahrleitner-Pammer A; Ng AYJ; Tohari S; Venkatesh B; Bonnard C; Reversade B; Klaushofer K; Al Kaissi A
    Bone; 2019 Jun; 123():48-55. PubMed ID: 30316000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy): First report from India.
    Chepuru R; Shaik AJ; Tandra SR; Gaddamanugu P; Alladi S; Kaul S
    Neurol India; 2018; 66(2):538-541. PubMed ID: 29547188
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
    Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
    Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous TREM2 c.549del; p.(Leu184Serfs*5) variant causing Nasu-Hakola disease in three siblings in a consanguineous Iraqi family: Case report and review of literature.
    Gilani N; Bitarafan F; Ozaslan M; Åsheim S; Heidari M; Garshasbi M
    Mol Genet Genomic Med; 2024 Jun; 12(6):e2476. PubMed ID: 38888203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation.
    Solje E; Hartikainen P; Valori M; Vanninen R; Tiihonen J; Hakola P; Tienari PJ; Remes AM
    Neurobiol Aging; 2014 Jul; 35(7):1780.e13-7. PubMed ID: 24612676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.